Retatrutide Research Material • LY3437943
Retatrutide 10 Vial Kit: Overview
Retatrutide (Reta), also identified as
LY3437943 or LY-3437943,
is an investigational peptide compound associated in the
scientific literature with activity at the
GIPR, GLP-1R, and GCGR receptor systems.
Royal Peptides supplies Retatrutide in multi-vial formats
exclusively as laboratory research material.
This research reference brings together compound identity,
receptor classification, 10-vial kit information, analytical
documentation, batch traceability, and related Royal Peptides
research resources in one location.
Retatrutide
LY3437943
GIPR
GLP-1R
GCGR
10-Vial Research Kits
Batch Traceability
About Retatrutide
Retatrutide (LY3437943) is an investigational Eli Lilly peptide studied for its activity at the GIP, GLP-1 and glucagon receptors. It is not an approved medicine. For identifiers, mechanism, the research timeline and Phase 3 data, see the full Retatrutide research profile.
This page covers the 10 vial kit format, batch documentation and bulk quantities. Need a smaller quantity? See Retatrutide single vials.
Research Kit Format
Retatrutide 10-Vial Research Kits
This product page is dedicated to
Retatrutide 10-vial research kits.
Available research quantities are organized through the product
variation selector above so laboratories can select among
currently available kit configurations without requiring a
separate indexed product page for every variation.
Each kit variation contains ten vials associated with the
selected nominal research quantity. Current pricing, variation
availability, and inventory status are displayed by the live
WooCommerce product record above.
Format10-Vial Configuration
Multi-vial research kits consolidate ten vials within a
single product configuration while retaining the applicable
product and batch identification.
VariationsMultiple Research Quantities
Available kit quantities are managed as variations of this
primary Retatrutide kit product rather than separate
near-duplicate product pages.
RecordsBatch Identification
Product and lot identification should be retained with
associated analytical and laboratory research records.
ProcurementBulk Research Requirements
Laboratories requiring quantities beyond standard
10-vial research kits can review Royal Peptides wholesale
and bulk research procurement information.
Analytical Verification
Retatrutide Batch Documentation & COAs
Royal Peptides maintains analytical documentation for
applicable Retatrutide production lots. Analytical reports
should be evaluated in relation to the
specific batch or lot represented by the tested sample
rather than treated as universal documentation for every
Retatrutide material.
The Royal Peptides Certificate of Analysis library provides a
central location for reviewing available analytical records and
matching applicable documentation to research material.
01Identify
Confirm the Retatrutide product, selected research quantity,
and available batch or lot identification.
02Match
Locate analytical documentation associated with the
corresponding production lot whenever lot-level information
is available.
03Review
Review the laboratory, sample identifiers, analytical
methods, reported measurements, and other information
contained in the report.
04Preserve
Retain relevant product, lot, analytical, receipt, and
storage records within the laboratory's research
documentation.
Research Traceability
Compound Record vs. Production Lot
Scientific databases describe the referenced Retatrutide
substance. Published literature describes material and
experimental conditions evaluated by individual investigators.
Analytical documentation, by contrast, can provide information
about the specific sample evaluated from an individual
production lot.
Royal Peptides therefore distinguishes
reference-compound information from
lot-specific analytical documentation.
Maintaining that distinction supports clearer research records
and material traceability.
Retatrutide Identity
Production Lot
Analytical Report
Sample Identification
Traceability
Research Procurement
10-Vial Kits & Bulk Research Quantities
Laboratories evaluating larger research quantities can compare
Retatrutide 10-vial kits with
wholesale and bulk research procurement.
Royal Peptides maintains separate resources for standard kit
formats and larger-volume research requirements.
The Royal Peptides wholesale research guide covers multi-vial
procurement, unit and price-per-milligram comparison,
analytical documentation, lot traceability, fulfillment, and
considerations relevant to larger research orders.
Related Research
Explore Retatrutide Research Resources
Royal Peptides maintains separate resources for different
research-material formats, analytical documentation, and
comparative research topics. These pages are kept distinct to
provide more specific information without duplicating the
complete 10-vial kit record.
RETATRUTIDE SOURCING GUIDE
Comparing Retatrutide research sources?
Review our guide to supplier evaluation, batch documentation,
analytical records and available Retatrutide research formats.
Read Retatrutide Sourcing Guide →
Retatrutide FAQ
Retatrutide Research Questions
What is Retatrutide?
Retatrutide is the official name associated with the
investigational peptide compound also identified as
LY3437943 or LY-3437943. Public pharmacology records
describe it as a triple receptor agonist associated with
GIPR, GLP-1R, and GCGR.
Is LY3437943 the same identifier associated with Retatrutide?
Yes. LY3437943 and LY-3437943 are development identifiers
associated with Retatrutide in public scientific and
regulatory records.
What receptor systems are associated with Retatrutide research?
Public pharmacology records describe the Retatrutide
reference compound as an agonist associated with the
glucose-dependent insulinotropic polypeptide receptor
(GIPR), glucagon-like peptide-1 receptor (GLP-1R), and
glucagon receptor (GCGR).
What is the CAS number associated with Retatrutide?
The validated GSRS substance record lists CAS Registry
Number 2381089-83-2 for Retatrutide. This is a
reference-compound identifier and does not replace
lot-specific analytical documentation for supplied
research material.
What does a Retatrutide 10-vial kit contain?
This product is organized as a 10-vial research kit.
Selecting a variation above determines the nominal research
quantity associated with each vial in that kit. Current
variations and inventory are displayed by the live product
selector.
Are Retatrutide single vials available separately?
Yes. Royal Peptides maintains a separate Retatrutide
single-vial product for laboratories requiring individual
research quantities rather than a 10-vial kit.
Is analytical documentation available for Retatrutide?
Royal Peptides maintains analytical documentation for
applicable research-material lots. Researchers should use
the available lot or batch information associated with the
material to locate corresponding records in the Royal
Peptides COA library.
Why should a Retatrutide COA be matched to its lot?
An analytical report describes the sample evaluated by the
testing laboratory. Matching documentation to the applicable
production lot supports traceability between the physical
research material and its analytical record.
Is Retatrutide an approved medicine?
Retatrutide remains an investigational compound. Royal
Peptides supplies its Retatrutide material exclusively for
laboratory, analytical, and scientific research and not for
human or veterinary use.
Does Royal Peptides provide Retatrutide dosing or administration instructions?
No. Royal Peptides does not provide dosing, prescribing,
injection, administration, treatment, or personal-use
instructions for this research material.
Scientific References
Public Retatrutide Records
Researchers can independently review authoritative public
records used for Retatrutide compound identification,
receptor classification, and clinical-development context.
NCATS / GSRS — Retatrutide
Validated substance record containing the Retatrutide name,
LY3437943 development identifiers, CAS number, FDA UNII,
peptide classification, sequence, and reference molecular
information.
NIH PubChem — Retatrutide / LY3437943
Public Retatrutide substance record identifying LY3437943 and
the published GIPR, GLP-1R, and GCGR receptor profile.
ClinicalTrials.gov — Retatrutide Studies
U.S. National Library of Medicine registry records for
clinical research involving Retatrutide / LY3437943.
Eli Lilly Research & Development Pipeline
Developer research and pipeline information concerning
investigational compounds and clinical development.
Research Use Only
Laboratory Research Material
Royal Peptides Retatrutide is supplied exclusively for
laboratory, analytical, and scientific research purposes.
It is not intended for human or veterinary use, ingestion,
injection, administration, pharmaceutical compounding,
diagnostic use, therapeutic use, clinical use, or personal
experimentation.
Royal Peptides
Need just one vial?
Retatrutide + Eloralintide Research Blend- Loretta
Price range: $90.00 through $660.00
View →
